Assessment of Psoas Muscle Index in Middle-Aged Type 2 Diabetes Patients: Impact of Insulin Therapy on Sarcopenia.

Published in: Tomography (Ann Arbor, Mich.) (2024)

Insulin therapy in T2DM patients, regardless of age or disease duration, positively impacts muscle mass, highlighting its potential in preserving muscular health and advocating for tailored treatment strategies in T2DM management.

Keyphrases

type diabetes
end stage renal disease
ejection fraction
chronic kidney disease
healthcare
middle aged
skeletal muscle
cardiovascular disease
public health
patient reported outcomes
risk assessment
insulin resistance